clinical trial · NCT07197775
Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
Endogenex, Inc.·—·not yet recruiting·n = 500
Type 2 Diabetes Mellitus (T2DM)Type2DiabetesDiabetes Mellitus, Type 2Type 2 DiabetesDiabetes
brief summary
This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.
started
Oct 1, 2025
primary completion
May 1, 2032
completion
May 1, 2032
last updated
Sep 29, 2025
detailed description
This is an observational registry that is designed to facilitate long-term patient follow-up for up to 5 years after an Endogenex procedure. It is structured to enable systematic longitudinal data collection on the safety and long-term clinical outcomes associated with the Endogenex System.
official title
Endogenex PULSE Registry
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol